Detalhe da pesquisa
1.
Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.
BMC Public Health;
22(1): 380, 2022 02 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35197024
2.
Safety and immunogenicity of two doses of quadrivalent meningococcal conjugate vaccine or one dose of meningococcal group C conjugate vaccine, both administered concomitantly with routine immunization to 12- to 18-month-old children.
Can J Infect Dis Med Microbiol;
25(4): 211-6, 2014 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25285126
3.
Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study.
Hum Vaccin Immunother;
19(1): 2160600, 2023 12 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36632042
4.
Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age.
Hum Vaccin Immunother;
18(6): 2099142, 2022 Nov 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35947774
5.
Risk Factors for Contracting Invasive Meningococcal Disease and Related Mortality: A Systematic Literature Review and Meta-analysis.
Int J Infect Dis;
119: 1-9, 2022 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35339714
6.
Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial.
Hum Vaccin Immunother;
18(5): 2052657, 2022 11 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35445641
7.
The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans.
Hum Vaccin;
7(6): 646-53, 2011 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21904120
8.
Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults.
Hum Vaccin;
7(7): 781-91, 2011 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21734467
9.
A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT.
Expert Rev Vaccines;
20(9): 1123-1146, 2021 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34365870
10.
Post-Marketing Surveillance Observational Study of Quadrivalent Meningococcal Diphtheria Toxoid Conjugate Vaccine (MenACWY-DT, MCV4/Menactra®) in the Republic of Korea, 2014-2019.
Infect Dis Ther;
10(1): 399-409, 2021 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33439463
11.
Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study.
Hum Vaccin Immunother;
17(3): 919-926, 2021 03 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33270487
12.
Immunogenicity and Safety of a Two-Dose Series of a Meningococcal (Groups A, C, W, and Y) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Men-ACWY-D) in Healthy Japanese Adults.
Jpn J Infect Dis;
74(3): 193-199, 2021 May 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33132297
13.
Longitudinal study of meningococcal carriage rates in university entrants living in a dormitory in South Korea.
PLoS One;
16(1): e0244716, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33507960
14.
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.
Clin Infect Dis;
51(10): 1127-37, 2010 Nov 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20954968
15.
Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany.
Emerg Infect Dis;
16(3): 465-72, 2010 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20202422
16.
The global meningitis genome partnership.
J Infect;
81(4): 510-520, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32615197
17.
Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales.
J Clin Microbiol;
47(11): 3577-85, 2009 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19759227
18.
Immunogenicity and tolerability in infants of a New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine.
Pediatr Infect Dis J;
28(5): 385-90, 2009 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19384263
19.
A Safety and Immunogenicity Study of a Single Dose of a Meningococcal (Groups A, C, W, and Y) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MEN-ACWY-D) in Healthy Japanese Participants.
Jpn J Infect Dis;
71(6): 402-407, 2018 Nov 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29962480
20.
New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months.
Pediatr Infect Dis J;
26(4): 345-50, 2007 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17414400